Intra-Cellular Therapies ...

131.70
0.00 (0.00%)
At close: Mar 25, 2025, 3:59 PM
131.74
0.03%
After-hours: Mar 25, 2025, 06:28 PM EDT

Intra-Cellular Therapies Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for ITCI stock have an median target of 99, with a low estimate of 74 and a high estimate of 132. The median target predicts a decrease of -24.83% from the current stock price of 131.70.

Target Low Average Median High
Price $74 $106.58 $99 $132
Change -43.81% -19.07% -24.83% 0.23%

Latest Analyst Insight Report

RBC Capital has downgraded Intra-Cellular Therapie... Unlock content with Pro Subscription

Updated Jan 22, 2025

Rating Aug 24Sep 24Oct 24Nov 24Jan 25Feb 25
Strong Buy 000000
Buy 534100
Hold 200042
Sell 000000
Strong Sell 000000
Total 7 3 4 1 4 2

Financial Forecast this Year

Revenue This Year
938.19M
from 680.85M
Increased by 37.8%
Revenue Next Year
1.45B
from 938.19M
Increased by 55.0%
EPS This Year
0.66
from -0.72
Increased by 8.3%
EPS Next Year
4.25
from 0.66
Increased by 543.9%